Sureda M - Search Results

1

[Spontaneous tumor regression. Report of 2 cases].

Sureda M, Subirá ML, Martín Algarra S, Prieto Valtueña J, Sangro B. Sureda M, et al. Med Clin (Barc). 1990 Sep 15;95(8):306-8. Med Clin (Barc). 1990. PMID: 2283912 Spanish.

2

High dose chemotherapy with peripheral blood stem cell (PBSC) support in solid tumours: preliminary results.

Martín Algarra S, Sureda M, Rebollo J, Henríquez I, Subirá ML. Martín Algarra S, et al. Among authors: sureda m. Bone Marrow Transplant. 1990 Jan;5 Suppl 1:60-1. Bone Marrow Transplant. 1990. PMID: 1969319 Clinical Trial. No abstract available.

3

[Intensive chemotherapy with 1-3 drugs and support with autologous myelopoietic cells extracted from the peripheral blood: the preliminary results].

Sureda M, Martín Algarra S, Henríquez I, Rebollo J, Vieitez J, Aristu J. Sureda M, et al. Rev Med Univ Navarra. 1990 Jan-Mar;34(1):51-4. Rev Med Univ Navarra. 1990. PMID: 1982905 Spanish.

4

[Intra-arterial chemotherapy, using the hepatic artery, in metastases of colorectal carcinoma].

Hidalgo OF, Gil AC, Campbell W, Hidalgo V, Santos M, Henríquez I, Martín S, Sureda M, Antón LM. Hidalgo OF, et al. Among authors: sureda m. Rev Med Univ Navarra. 1987 Jul-Sep;31(3):169-76. Rev Med Univ Navarra. 1987. PMID: 3333892 Review. Spanish.

5

Therapeutic drug monitoring of nivolumab in routine clinical practice. A pilot study.

Sureda M, Mata JJ, Catalán A, Escudero V, Martínez-Navarro E, Rebollo J. Sureda M, et al. Farm Hosp. 2020 Apr 17;44(3):81-86. doi: 10.7399/fh.11319. Farm Hosp. 2020. PMID: 32452306 English.

6

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs).

Martínez-Navarro EM, Rebollo J, González-Manzano R, Sureda M, Evgenyeva E, Valenzuela B, Fernández FJ, Forteza J, Brugarolas A. Martínez-Navarro EM, et al. Among authors: sureda m. Clin Transl Oncol. 2011 Nov;13(11):812-8. doi: 10.1007/s12094-011-0739-1. Clin Transl Oncol. 2011. PMID: 22082647

7

Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question.

Sureda M, Calvo E, Mata JJ, Escudero-Ortiz V, Martinez-Navarro E, Catalán A, Rebollo J. Sureda M, et al. Clin Transl Oncol. 2021 Aug;23(8):1511-1519. doi: 10.1007/s12094-021-02563-3. Epub 2021 Feb 13. Clin Transl Oncol. 2021. PMID: 33583005 Review.

8

Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis.

Valenzuela B, Nalda-Molina R, Bretcha-Boix P, Escudero-Ortíz V, Duart MJ, Carbonell V, Sureda M, Rebollo JP, Farré J, Brugarolas A, Pérez-Ruixo JJ. Valenzuela B, et al. Among authors: sureda m. AAPS J. 2011 Mar;13(1):72-82. doi: 10.1208/s12248-010-9249-2. Epub 2011 Jan 6. AAPS J. 2011. PMID: 21210260 Free PMC article.

9

Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy: A Pilot Study.

Rebollo J, Sureda M, Martinez EM, Fernández-Morejón FJ, Farré J, Muñoz V, Fernández-Latorre F, Manzano RG, Brugarolas A. Rebollo J, et al. Among authors: sureda m. Am J Clin Oncol. 2017 Apr;40(2):140-145. doi: 10.1097/COC.0000000000000116. Am J Clin Oncol. 2017. PMID: 25144266

10

Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study.

Sureda M, Rebollo J, Martínez-Navarro EM, Fernández-Morejón FJ, Farré J, Muñoz V, Bretcha-Boix P, Duarte M, Manzano RG, Crespo A, Del Carmen Redal M, Valenzuela B, Brugarolas A. Sureda M, et al. Clin Transl Oncol. 2018 Jun;20(6):785-793. doi: 10.1007/s12094-017-1789-9. Epub 2017 Nov 20. Clin Transl Oncol. 2018. PMID: 29159791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page